PCMA on National Diabetes Month: PBMs lowering insulin costs, providing support to patients

November 16, 2020 by Chain Drug Review How PBMs Reduce Insulin Cost, National Diabetes Month, Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott Leading Headlines, Pharmacy

WASHINGTON — In recognition of National Diabetes Month, the Pharmaceutical Care Management Association (PCMA) is outlining how pharmacy benefit managers, PBMs, are working to lower insulin costs and creating programs to support people with diabetes and improve health outcomes. “PBMs have been able to moderate insulin costs for most people with insurance,” said PCMA president and CEO